Evaluating Alzheimer's Disease Progression by Modeling Crosstalk Network Disruption

被引:6
|
作者
Liu, Haochen [1 ]
Wei, Chunxiang [1 ]
He, Hua [1 ]
Liu, Xiaoquan [1 ]
机构
[1] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China
来源
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; disease progression; crosstalk network; diagnosis; multi-marker; CSF BIOMARKERS; TAU PATHOLOGY; REPRESENTATION; DIAGNOSIS; DECLINE; MARKERS;
D O I
10.3389/fnins.2015.00523
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A beta, tau, and P-tau have been widely accepted as reliable markers for Alzheimer's disease (AD). The crosstalk between these markers forms a complex network. AD may induce the integral variation and disruption of the network. The aim of this study was to develop a novel mathematic model based on a simplified crosstalk network to evaluate the disease progression of AD. The integral variation of the network is measured by three integral disruption parameters. The robustness of network is evaluated by network disruption probability. Presented results show that network disruption probability has a good linear relationship with Mini Mental State Examination (MMSE). The proposed model combined with Support vector machine (SVM) achieves a relative high 10 fold cross validated performance in classification of AD vs. normal and mild cognitive impairment (MCI) vs. normal (95% accuracy, 95% sensitivity, 95% specificity for AD vs. normal; 90% accuracy, 94% sensitivity, 83% specificity for MCI vs. normal). This research evaluates the progression of AD and facilitates AD early diagnosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] MODELING DISEASE PROGRESSION IN ALZHEIMER'S DEMENTIA TO INFORM HTA (CEA)
    Green, C.
    Zhang, S.
    VALUE IN HEALTH, 2014, 17 (07) : A563 - A563
  • [32] A Discriminative Event Based Model for Alzheimer's Disease Progression Modeling
    Venkatraghavan, Vikram
    Bron, Esther E.
    Niessen, Wiro J.
    Klein, Stefan
    INFORMATION PROCESSING IN MEDICAL IMAGING (IPMI 2017), 2017, 10265 : 121 - 133
  • [33] Deep Learning Based Multimodal Progression Modeling for Alzheimer's Disease
    Yang, Liuqing
    Wang, Xifeng
    Guo, Qi
    Gladstein, Scott
    Wooten, Dustin
    Li, Tengfei
    Robieson, Weining Z.
    Sun, Yan
    Huang, Xin
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2021, 13 (03): : 337 - 343
  • [34] MODELING ALZHEIMER'S DISEASE (AD) PROGRESSION ON A PATHOLOGICAL TIMELINE.
    Chua, L.
    Willis, B. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S13 - S13
  • [35] Application of a growth curve approach to modeling the progression of Alzheimer's disease
    Stern, Y
    Liu, XH
    Albert, M
    Brandt, J
    Jacobs, DM
    DelCastilloCastaneda, C
    Marder, K
    Bell, K
    Sano, M
    Bylsma, F
    Lafleche, G
    Tsai, WY
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1996, 51 (04): : M179 - M184
  • [36] Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks
    Wang, Tingyan
    Qiu, Robin G.
    Yu, Ming
    SCIENTIFIC REPORTS, 2018, 8
  • [37] Posterior Cingulate Cortex Network Predicts Alzheimer's Disease Progression
    Lee, Pei-Lin
    Chou, Kun-Hsien
    Chung, Chih-Ping
    Lai, Tzu-Hsien
    Zhou, Juan Helen
    Wang, Pei-Ning
    Lin, Ching-Po
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [38] Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease
    Bayard Rogers
    Scientific Reports, 14 (1)
  • [39] Evaluating frontoparietal network topography for diagnostic markers of Alzheimer's disease
    Rogers, Bayard
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Neural network modeling of memory gradient in Alzheimer's disease
    Hamilton, JL
    Micheli-Tzanakou, E
    PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6: MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING, 1997, 19 : 1367 - 1370